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BACKGROUND:  The  implementation  of  biocatalytic  oxidation  processes  is  currently
limited by the requirement of expensive cofactors that must be efficiently recycled. In this
research,  a  sustainable  approach  based  on  immobilized  self-sufficient  Baeyer-Villiger
monooxygenases is discussed. 
RESULTS: A bifunctional biocatalyst  composed by an NADPH-dependent cyclohexanone
monooxygenase  (CHMO)  and  an  NADP+-accepting  phosphite  dehydrogenase  (PTDH)
catalyzes ε-caprolactone synthesis from cyclohexanone, using phosphite as a cheap sacrificial
substrate  for  cofactor  regeneration.  Several  immobilized  derivatives  of  the  fused enzyme
have  been  prepared  with  high  immobilization  yield  (97%);  the  one  obtained  by affinity
adsorption  on  Co-IDA (IDA:  iminodiacetic  acid)  support  has  shown to  be  highly  stable
conducting to average yields of 80 % after 18 reaction cycles. 
CONCLUSIONS: The immobilized self-sufficient monooxygenase has demonstrated to be
able to perform Baeyer Villiger oxidation with efficient cofactor recovery and biocatalyst
recycling. The proposed biocatalytic process offers access to valuable molecules with high
atom economy and limited waste generation. 
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Currently,  oxygen  functionalities  represent  the  most  abundant  and  important  functional
groups  in  chemicals  and  materials. Thus,  oxidation  reactions  are  essential  in  several
industries.  Conventional  chemical  oxidations  are  still  widely  applied  in  industrial
environments  for  catalyzing  oxidative  reactions,  even  though  they  entail  several
disadvantages  mainly  related  to  environmental  and  safety  issues.1 These  drawbacks  are
consequence  of  the  use  of  i)  toxic  or  hazardous  oxidants  (organic  peracids,  bleach,  and
bromide), ii) organic solvents and iii) heavy metal catalysts. Regarding oxidants, oxygen or
air are the preferable compounds but aerating flammable solvents implies a significant safety
concern that can only be addressed if water is used as reaction media. In that sense, the use of
biocatalysts comes up as a greener and safety alternative since they can catalyze reactions in
aqueous media.1 Nevertheless, industrial scale implementation of biocatalytic processes using
oxidoreductases is still scarce.2 
One of  the  main  hindrances  of  oxidoreductases  to  reach  industrial  environments  is  their
requirement of stoichiometric amounts of expensive cofactors, usually NAD(P)H/NAD(P)+.
This  cofactor  dependence often leads  to a  non-economically viable  process.2,3 Studies  on
solving this problem can be found in the literature based on two main approaches: i) the use
of whole cells instead of isolated enzymes in order to take advantage of the own cellular
metabolism and ii) the development of alternative systems for cofactor regeneration when
isolated enzymes are employed. The use of whole cells has several disadvantages such as
substrates and/or product diffusional limitations through the cell membrane or the generation
of  non-desirable  by-products.3 Regarding  the  use  of  regenerating  systems,  several
methodologies have been developed such as the chemical,  electrochemical and enzymatic
regeneration. However, the already available chemical and electrochemical methods do not






























aspects.4,5 Thus, the use of enzymes for cofactor regeneration has come up as a more efficient
and greener option.6 
Baeyer-Villiger  monooxygenases  (BVMO)  are  flavin-dependent  enzymes  capable  of
inserting an oxygen atom between a C-C bond adjacent to a carbonyl group, producing esters
or  lactones.  These  oxidized  ketones  are  key  building  blocks  for  the  synthesis  of  target
molecules  in  pharma,  food,  fine  and  specialty  chemical  and  material  sectors.7,8 Besides,
BVMOs have been reported to be able to oxidize C=C bond yielding epoxides,  and hetero-
atom-containing molecules (e.g. amines or organic sulfides).9–11 
Herein,  an  innovative  self-sufficient  Baeyer-Villiger  monooxygenase  is  studied  as  an
immobilized  biocatalyst  for  such biotransformations.   The oxidation  of  cyclohexanone to
obtain  ε-caprolactone,  a  compound  of  industrial  interest  for  polymer  synthesis  (e.g.
polycaprolactone and nylon 6)12 is employed as a case study in this paper (Scheme 1). The
biocatalyst  is  a  fused  enzyme  made  up  of  an  NADPH-dependent  cyclohexanone
monooxygenase  (CHMO)  (EC  1.14.13.22)  and  an  NADP+-accepting  phosphite
dehydrogenase (PTDH) (EC 1.20.1.1), used for cofactor regeneration.13,14 This bifunctional
biocatalyst allows a multi-enzymatic one-pot reaction that requires a catalytic concentration
of the cofactor NADP+, recycling the cofactor simultaneously by using phosphite as a cheap
sacrificial  substrate.  The  behavior  of  the  immobilized  self-sufficient  CHMO/PTDH  as  a
biocatalyst has been studied, looking for stable operation of the oxidative reaction with total
cofactor recycling and efficient re-use of the fused enzyme.
Materials and Methods
Materials
High-density metal free agarose resins and 10% cross-linked agarose beads were purchased
from Agarose Beads Technologies (Madrid, Spain), Eupergit®CM was acquired from Sigma-































engineering (Shenzhen, Guangdong, China). All other reagents were of analytical grade and
obtained from various commercial suppliers.
Enzyme production and purification
Chemically  competent  E.  coli NEB10β  cells  were  transformed  with  the  previously
described,14 pBAD derived pCRE-CHMO vector  harboring a 6xHis-PTDH-CHMO fusion
construct. A 5 mL preculture was grown overnight at 37 °C from a single colony and then
transferred to a 5 L flask with 1 L of TB medium containing 0.02% L-arabinose and 50
µg/mL ampicillin. The protein was expressed at 24 °C for approximately 40 hours shaking at
135 rpm. Cells were then harvested by centrifugation (6,000×g for 15 min at 4 °C, JA-10.5
rotor, Beckman Coulter, USA) and resuspended in 5% of the culture volume with 50 mM
Tris-HCl buffer pH 7.5. Cell-free extract (CFE) was prepared by sonication and subsequent
centrifugation (15,000×g for 45 min at 4 °C, JA-17 rotor, Beckman Coulter). An empty XK
26/20 column (GE Healthcare Life Sciences, Chicago, USA) was packed with approximately
30 mL Ni-Sepharose (GE Healthcare Life Sciences) and connected to a Watson Marlow 120
peristaltic pump. The column was equilibrated with buffer (50 mM Tris-HCl pH 7.5) before
the CFE was loaded. The column was washed with 3 column volumes (CV) of buffer and 3
CV of the buffer with 5 mM imidazole. Subsequently,  the protein was eluted with buffer
containing 500 mM imidazole. 15 mL batches of the purified protein solution were desalted
on a HiPrep 26/10 desalting column (GE Healthcare Life Sciences), and then shock frozen in
liquid N2 after addition of 2% (w/v) sucrose for improved retention of enzymatic activity
after lyophilisation.15 The lyophilized protein was stored at -20 °C until further use. Per liter
of culture, approximately 180 mg of pure enzyme was yielded.
Enzyme activity assays and protein content analysis
CHMO  activity  was  determined  spectrophotometrically  by  monitoring  the  decrease  of
NADPH at 340 nm (ε= 6.22 mM-1 cm-1),  using cyclohexanone as substrate.  The reaction
mixture contained 50 mM Tris-HCl (pH 8.5), 0.5 mM cyclohexanone, 0.1 mM NADPH and
































of enzyme required to catalyze the conversion of 1 μmol of NADPH to NADP+ per minute at
20  °C  and  pH  8.5.  PTDH  activity  was  measured  spectrophotometrically  following  the
formation of NADPH at 340 nm. The reaction mixture contained 50 mM 3-(N-Morpholino)
propanesulfonic  acid,  4-morpholinepropanesulfonic  acid  (MOPS)  (pH  7.25),  1  mM
phosphite, 0.5 mM NADP+ and the appropriate amount of enzyme sample. One unit of PTDH
was defined as the amount of enzyme activity required to catalyze the conversion of 1 μmol
of NADP+ to NADPH per minute at 25 °C and pH 7.25. All activity assays were carried out
using  a  Cary  50  Bio  UV–visible  spectrophotometer  (Palo  Alto,  USA).  Soluble  enzyme
measurements were performed using 1.4 mL quartz cuvettes; immobilized enzyme activity
was measured using 3.5 mL quartz cuvettes and magnetic stirring. 
Total  protein  content  was  determined  using  Bradford  Protein  Assay  Kit  (Thermo  Fisher
Scientific,  Waltham,  USA),  with  bovine  serum  albumin  as  standard.  The  percentage  of
CHMO/PTDH in the lyophilized powder was determined by SDS-PAGE (NuPAGE 12%,
Invitrogen, USA) and densitometry with Image LabTM Software (Bio-Rad, USA).
Influence of pH on enzyme activity and stability
The pH dependence of CHMO and PTDH activity was evaluated by performing enzymatic
activity assays replacing Tris-HCl or MOPS buffer by 50 mM acetate buffer (pH 5.0), Tris-
maleate buffer (pH 6.0-7.5), Tris-HCl buffer (pH 8.0-9.0), or carbonate-bicarbonate buffer
(pH 10.0). Enzyme stability was determined by placing 2 U of CHMO or PTDH on 2 mL of
buffer solution and incubating each medium at 25 °C and mild agitation; aliquots were taken
at different times and enzyme activity was measured.
Immobilization on agarose based supports
Metal-chelate support charged with Ni+2 (Ni-IDA; IDA: Iminodiacetic acid) was prepared by
incubating the metal free agarose resin with a 0.2 M solution of NiSO4 (pH 6.0-7.0); Co-IDA
was prepared by incubating the agarose resin with 0.2 M solution of CoCl2.16 Immobilization
of  CHMO/PTDH  on  Ni/Co-IDA was  carried  out  by  suspending  the  support  on  50  mM
Na2HPO4, 300 mM NaCl, 20 mM imidazole solution (pH 8.0) in a 1:10 proportion (volume

































and mild agitation. MANA-agarose (MANA: monoaminoethyl-N-aminoethyl) was prepared
by etherification of 10% cross-linked agarose beads with glycidol followed by oxidation with
periodate and subsequent modification of the highly activated support with ethylendiamine.17
CHMO/PTDH  was  covalently  immobilized  on MANA-agarose  with  N-(3-
Dimethylaminopropyl)-N'-ethylcarbodiimide (EDAC)  as  an  activating  agent.  For  this
purpose,  the  support  was  suspended  in  25  mM  MES  buffer  (pH  6.5)  (1:10  volume  of
support/total volume); CHMO/PTDH was added and left to ionically adsorb to the support
for 15 minutes. Then EDAC was added to a final concentration of 25 mM in MES buffer and
the mixture was left for 2 hours to allow the activation of the carboxylic groups transforming
the ionic adsorption to a covalent one. The immobilization was carried out at 25 °C and mild
agitation. Immobilization on Eupergit®CM was carried out by hydrating the resin for 24 hours
in distilled water. After the hydration stage the resin was filtered and placed in 1 M potassium
phosphate  buffer  (pH  8.0)  in  a  1:10  ratio  (volume  of  support/total  volume),  then
CHMO/PTDH was added and left to immobilize for 2 hours at 25 °C and mild agitation.
Finally, the free epoxy groups of the resin were blocked with 0.2 M 2-mercaptoethanol for 4
hours at 4 °C. To characterize the time course of the immobilization, samples of suspension
and supernatant were periodically withdrawn and CHMO activity was measured. In parallel,
CHMO activity in a blank without agarose support was monitored along time. 
Immobilization yield was defined as the difference between the total starting activity and the
total residual activity in the supernatant related to the total starting activity (Eq. 1).




Retained activity was defined as the difference between the total residual suspension activity
and the total residual activity in the supernatant in relation to the total starting activity (Eq. 2).
Retained activity (% )  =  Final suspension activity - Final supernatant activity
Initial suspension activity
×100   (2)































Reactions were performed in a roller mixer at 25 °C at different pH: pH 7.0 (150 mM sodium
phosphate buffer), pH 7.5 (150 Mm Tris-maleate buffer) or pH 8.0-8.5 (150Mm Tris-HCl
buffer). The reactions were carried out in a medium containing 25 mM cyclohexanone, 1mM
NADP+,  and  50  mM  phosphite.  For  soluble  enzyme,  5  U  of  the  enzyme,  based  on
monooxygenase activity, was added to the medium with a final reaction volume of 5 mL.
Reactions with immobilized enzyme were carried out employing 1 mL of support loaded with
10 U of the enzyme, in a final reaction volume of 10 mL.
The atom economy (Eq. 3) and the reaction efficiency (Eq. 4) have been calculated as:
Atom economy= Molecular mass of ε- caprolactone
Molecular mass of all the reactants   (3)
Reaction efficiency=Atom economy ×Product yield   (4)
Reusability of immobilized bifunctional CHMO/PTDH
To evaluate the performance of the immobilized biocatalyst on multiple synthesis cycles, 3
mL of support (Co-IDA or MANA-agarose) loaded with 60 U of enzyme were added to the
reaction medium with a final volume of 30 mL. CHMO activity and cofactor regeneration
were assayed during the first cycle. After each cycle the support was recovered and washed
with 150 mM sodium phosphate buffer (pH 7.0), then new reaction medium was added and
substrate conversion and product yield were quantified.
Quantification of cyclohexanone and ε-caprolactone
Both  ketone  and  lactone  concentrations  were  analyzed by gas  chromatography.  Reaction
samples were extracted with 20 volumes of ethyl acetate containing methyl benzoate (1 g/L)
as internal standard, and the organic phase was analyzed using a 7890A gas chromatograph
(Agilent Technologies, USA) equipped with an HP-INNOWAX 19095N-123 column (30 m,
0.53 mm, 1μm, Agilent Technologies).  The column temperature was held at  50 °C for 2
minutes and increased to 240 °C at 20 °C/min and held at final temperature for 0.5 minutes.
The  injector  temperature  was  kept  at  250  °C;  for  the  flame  ionization  detector,  the
temperature was 300 °C. Helium was used as a carrier gas at a flow rate of 16 mL/min. The
side reaction product identity was confirmed by exact mass determination performed in a

































in negative polarity (Bruker Technologies, USA). Exact mass calibration was performed with
sodium formate. MS-ESI −: m/z=131.0712, calcd. for C6H12O3: 131.0703.
Results and Discussion
Characterization of the biocatalyst: CHMO and PTDH
The bifunctional biocatalyst - cloned and expressed in  E. coli  - was tailored with a hexa-
histidine tag to facilitate  its  purification by metal-chelate  affinity chromatography.  It  was
obtained as a single fusion protein made up of CHMO from  Acinetobacter calcoaceticus
NCIMB987118 covalently  linked,  through  a  short  peptide,  to  a  PTDH  variant  from
Pseudomonas stutzeri WM8819 for NADPH regeneration.
Protein content and enzymatic activity of both enzymes were tested, resulting in a specific
activity of 3.2 U/mg of protein and 0.8 U/mg of protein for CHMO and PTDH, respectively.
Figure 1 shows the activity and stability at different pH values for both enzymes. CHMO has
a maximum activity at pH 9.0; while 7.5 is the optimum pH for PTDH (see Figure 1A, and
1B). These data are in accordance with previously reported results18,20 and indicate that the
fusion did not affect the pH dependence of the fused enzymes as compared to the non-fused
enzymes. The pH stability of the bifunctional biocatalyst has been studied in order to set up
the  optimum conditions  for  biocatalyst  immobilization  and  for  ε-caprolactone  synthesis.
CHMO was found to be very unstable at pH lower than 7.0 and higher than 9.0; being more
stable in the range 8.0-9.0 (Figure 1C). After 7 hours of incubation at pH 7.0 and 7.5, the
enzyme retained more than 40% of the initial activity. Conversely, PTDH demonstrated to be
quite stable in the studied range, retaining around 70% of the initial activity at pH 7.0 and
7.5, and above 80% for pH 8.0-9.0 (Figure 1D). More acidic pH media were not studied for
PTDH since CHMO already proved to be unstable at pH<7.0.
Coupled oxidation and cofactor regeneration
The evaluation of the bifunctional biocatalyst entailed the selection of reaction conditions
































regeneration. Taking into account the activity and stability results, four pH values (7.0, 7.5,
8.0 and 8.5) were selected to evaluate the behavior of the self-sufficient monooxygenase.
Phosphite and NADP+ were used as substrates, thus forcing the cofactor regeneration to start
before the CHMO-catalyzed reaction (see Scheme 1). The oxidation of cyclohexanone with
the  concurrent  regeneration  of  NADPH  catalyzed  by  soluble  CHMO/PTDH  took  place
successfully in the whole selected pH range with complete substrate conversion in 3 hours.
Figure 2 shows the time evolution of the reactions performed at pH 7.0 and 8.5. Although
complete  conversion  of  the  ketone  substrate  was  observed  with  1  U  of  CHMO/mL of
reaction, lactone yield was lower than 100% in all cases. As pH increased, lower yields were
obtained, moving from 88% at pH 7.0 to 75 % at pH 8.5, and incubation of the reaction
mixture  for  a  longer  time  resulted  in  a  decrease  of  the  synthesized  ε-caprolactone
concentration  in  the  alkaline  range (see  Figure 2B for  pH 8.5 as  an example).The mass
imbalance  suggested  the  presence  of  a  side  reaction.  To  confirm  this  hypothesis,
cyclohexanone and  ε-caprolactone were incubated separately for 24 hours in the reaction
medium at pH 7.0-8.5; initial and final concentration of the compounds were compared (data
not shown). Cyclohexanone exhibited very high stability for all the pH tested; on the other
hand,  ε-caprolactone  concentration  decreased  at  alkaline  pH  values.  The  product  of  the
decomposition  of  ε-caprolactone  was  identified  as  6-hydroxyhexanoic  acid,  produced  by
lactone hydrolysis. A compound with an exact mass corresponding to the mentioned hydroxyl
acid  was  identified  in  samples  of  the  reaction  medium (see  Materials  and  Methods).  In
consequence,  further  reaction  experiments  were  carried  out  at  pH  7.0  to  minimize  ε-
caprolactone ring opening.
Biocatalyst immobilization
The  immobilization/stabilization  of  the  bifunctional  biocatalyst  was  intended  by  affinity
adsorption and by covalent attachment. Based on successful immobilization of different poly-
His-tagged  enzymes  by affinity  adsorption,16,21 the  immobilization  on  two  metal-chelated
































IDA retained higher activities than the Ni-IDA ones. The process of immobilization on Co-
IDA was completed after 20 minutes resulting in an immobilization yield of 97.5% and a
retained activity of 90.6% (see Table 1). As an alternative, enzyme immobilization through
covalent  attachment  on  different  supports  (MANA-agarose  and  Eupergit®CM)  was  also
investigated. The immobilization on MANA-agarose was performed in a two-step procedure:
an ionic adsorption followed by covalent bonding. The ionic stage was completed after 15
minutes  with a 99% immobilization yield.  EDAC was then added as  carboxyl  activating
agent for promoting amide bond formation with the amine groups from the support. Under
the best conditions (25mM EDAC for 2 hours), the immobilized biocatalyst showed a final
retained activity of 69% (see Table 1). Immobilization on Eupergit®CM was also intended,
obtaining high immobilization yield values (>95%) but very low retained activities (16%).
The activity loss could be explained because the enzyme is covalently attached to the epoxy
groups of the support mainly through their amino residues which are closely located to the
catalytic site of CHMO.
Reactions catalyzed by immobilized CHMO/PTDH
The biocatalyst  immobilized on Co-IDA was tested in a synthesis reaction at comparable
conditions to the reactions with soluble enzyme presented in Figure 2A. An immobilized
derivative with 10 CHMO U/mL of support was prepared and the reaction was performed by
using  1  U  of  CHMO/mL of  reaction  at  25°C  and  at  pH  7.0  to  prevent  ε-caprolactone
hydrolysis. Substrate oxidation and product formation rates were very similar to the ones
obtained with soluble enzymes at 1 U of CHMO/ mL of reaction (Figure 3), suggesting the
absence  of  diffusional  restrictions.  Full  ketone  conversion  was achieved after  3  hours  of
reaction and more significantly, the immobilized biocatalyst retained 100 % of its activity
after all substrate had been consumed. On the contrary, soluble enzymes showed substantial
deactivation over time (see Figure 2).The cofactor regeneration efficiency can be emphasized































and  4B  show  the  cofactor  profiles  for  reactions  catalyzed  by  soluble  and  immobilized
biocatalysts.  As already stated,  the cofactor was initially added as NADP+ and an almost
constant concentration of both oxidized and reduced forms is observed after a short initial
reaction time. For this to happen, the rates of formation and consumption of NADP+ and
NADPH have to be the same and take on the value of the limiting (slower) reaction. As it can
be  observed,  NADP+ is  the  most  abundant  form throughout  the  reaction  and  only  once
cyclohexanone is completely oxidized, the equilibrium shifts completely towards NADPH.
This behavior is common for both soluble and immobilized bifunctional catalyst and suggests
the cofactor regeneration to be the limiting step in the reaction. Kinetic parameters for soluble
CHMO fused to PTDH have been previously reported,14 being kcat 13 s-1 for CHMO and 1.5 s-
1 for  PTDH.  As  the  relative  amount  of  both  enzyme  activities  is  maintained  in  the
immobilized  enzyme,  this  substantial  difference  could  explain  the  relative  low  NADP+
conversion. After complete cyclohexanone consumption, NADP+ is almost totally converted
to NADPH by the PTDH activity.
Reutilization of immobilized enzyme in multiple reaction cycles
Optimization  of  the  reaction  conditions  has  a  substantial  influence  in  preparative  scale
conversions  catalyzed  by Baeyer-Villiger  monooxygenases.  On this  matter,  other  authors
have  dealt  with  the  stabilization  of  CHMO  through  immobilization  and  the  consecutive
reutilization of the biocatalyst.22,23 
The substantial improvement in stability by the immobilized bifunctional biocatalyst presents
the possibility of its reutilization in successive cycles of oxidation and cofactor regeneration.
With that aim, the biocatalysts immobilized on Co-IDA and MANA-agarose were employed,
increasing their concentration to 2 U/mL of reaction to reduce the reaction time. The first
reaction cycle was performed until 100% conversion was achieved; the reaction profiles are
presented in Figure 5A and 5B. Total cyclohexanone conversion was reached after 2 hours for































agarose, being both fully stable. However, a different course in the evolution of the cofactor
concentration over time was observed for the enzyme immobilized on Co-IDA when using 2
U/mL of reaction (Figure 4C). Although a constant level for each reduced and oxidized form
of  the  cofactor  was  again  observed,  the  concentration  of  NADPH  was  higher  than  the
concentration of NADP+ along the reaction time, and there was no accumulation of NADP+
as occurred at 1 U/mL. Aiming to understand these cofactor profile changes, initial rates of
CHMO  and  PDTH-catalyzed  reactions  were  calculated  as  the  rate  of  ε-caprolactone
formation and NADP+ depletion respectively, and are reported in Table 2. As indicated by the
initial  effectiveness  factor  η0 (calculated as  the  initial  reaction  rate  divided by the initial
reaction  rate  in  absence  of  diffusional  restrictions,  i.e.  soluble  enzymes),  there  are  no
diffusional restrictions for the Co-IDA derivative at 1 U/mL of reaction. By contrast, at 2
U/mL, the CHMO-catalyzed reaction is diffusion-limited (η0<1), while the PTDH-catalyzed
reaction remains non-limited. This fact, at longer times, could explain qualitatively the profile
shown in  Figure  4C in  which  the  cofactor  recycling  reaction  is  less  limiting.  Moreover,
according  to  the  data  in  Table  2,  for  the  MANA-agarose  derivative,  both  reactions  are
diffusion limited (η0<1). 
As previously stated,  the stability of both immobilized bifunctional  biocatalysts  has been
quantified by employing them in repeated reaction cycles. Each subsequent cycle lasted the
same time and substrate conversion and product yield were determined. For the last cycle, the
reaction progress was monitored until complete conversion was reached again. The results for
CHMO/PTDH  immobilized  on  MANA-agarose  are  presented  in  Figure  6A.  As  already
indicated, total cyclohexanone oxidation in the first cycle was reached within 2.5 hours (cycle
time) and 80 % ε-caprolactone yield was obtained. The biocatalyst was continuously reused
for up to 10 cycles with a sustained decrease of conversion and product yield due to loss of






























cyclohexanone oxidation was reached in 2.5 hours (cycle time) and 8 hours were necessary to
achieve 99% conversion of the substrate.
The performance of the biocatalyst immobilized on Co-IDA is depicted in Figure 6B. In the
first cycle, full conversion of cyclohexanone and a product yield of 84% were achieved after
2 hours (cycle time); furthermore, the immobilized biocatalyst was successfully reused for up
to 18 cycles. In contrast to the results observed with MANA-agarose, almost total conversion
of cyclohexanone was achieved for 10 cycles, and in further cycles, the conversion decreased
moderately.  After  18  cycles,  the  oxidation  reaction  catalyzed  by  the  immobilized
CHMO/PTDH  still  reached  74% conversion  and  64% of  product  yield  in  2  hours.  The
reutilization of CHMO/PTDH immobilized on MANA-agarose led to a final biocatalyst yield
of 8.5 mg of ε-caprolactone/U of CHMO; for the enzyme immobilized in Co-IDA, this value
increased to 20.6 mg of ε-caprolactone/U of CHMO (see Table 3). These values represent a
7.7 and 17 fold increased respectively when compared to the yields for just one cycle.
Conclusions
The CHMO/PTDH bifunctional biocatalyst  has shown to be able  to  catalyze the Baeyer-
Villiger  oxidation  reaction  with  simultaneous  cofactor  regeneration  employing  a  cheap
sacrificial substrate. The immobilized biocatalyst derivatives have been prepared with high
retained activities leading to dramatic increase in stability. The results demonstrate that the
biocatalyst immobilized on Co-IDA is very stable, catalyzes the target reaction efficiently,
and proper cofactor recycling can be achieved. Moreover, the biocatalyst can be reused for up
to 18 reaction cycles. Table 3 summarizes the comparison of the studied alternative with a
chemical  oxidation  with  oxygen  (air)  and acetaldehyde,24 and  a  biocatalytic  one  without
cofactor recycling. The atom economy and reaction efficiency of the biocatalytic process with
immobilized bifunctional biocatalyst is much higher than the biocatalytic oxidation without































process, with the advantage of milder operation conditions. Furthermore, the high stability of
CHMO/PTDH immobilized on Co-IDA allows operation with a sustained high yield (87.7%)
and reaction efficiency during 10 cycles and the process can be extended up to 18 cycles with
a  minor  reduction  of  ε-caprolactone  yield  (80.5%).  Although  further  case-by-case
optimization  of  substrate  concentrations  and  oxygen  transfer  rate  is  necessary,  the
immobilized  self-sufficient  oxidase  has  demonstrated  to  be  a  promising  biocatalyst  for
Baeyer-Villiger  oxidations,  with  the  advantages  of  stable  operation,  efficient  cofactor
recycling, cheap sacrificial substrate, neutral pH, and biocatalyst recovery. 
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Table 1. Immobilization yield and retained activity of CHMO/PTDH immobilized on agarose
based supports and Eupergit®CM. For immobilization conditions see Materials and Methods










*No substrate transfer limitations were found at this enzymatic load
Table  2. Initial  reaction  rate  and  initial  effectiveness  factor  for  ε-caprolactone  synthesis








































Soluble 1 9.1 9.1  0.93 0.93  
Co-IDA
derivative 1 9.5 9.5 ≈1 0.99 0.99 ≈1
Co-IDA
derivative 2 12.3 6.1 0.67 2.2 1.1 ≈1
MANA
derivative 2 10 5 0.55 0.66 0.33 0.35
r0 CHMO: Initial  rate of ε-caprolactone formation;  r0,sp CHMO: Specific initial  rate of ε-
caprolactone formation (per unit of activity); r0  PTDH: Initial rate of NADP+ consumption;
r0,sp PTDH:  Specific  initial  rate  of  NADP+ consumption  (per  unit  of  activity);  η0,CHMO:
Effectiveness factor for the CHMO catalyzed reaction at  time = 0 ; η0,PTDH:  Effectiveness
factor for the PTDH-catalyzed reaction at time = 0. The units of the bifunctional catalyst are
referred as CHMO units. Initial concentrations: [cyclohexanone] = 25 mM; [phosphite] = 50
mM; [NADP+] = 1 mM. The reactions were performed at 25 °C and pH 7.0.
Table 3. Reaction efficiency and product production for ε-caprolactone synthesis catalyzed
























and calculated data for a biocatalysis without cofactor recycling are presented for comparison
purposes.
* Hypothetical process assumed to render the same yield as 1 cycle with the immobilized































(1 cycle) 54.7 84 46 71.6 1.2
Immobilized 
(10 cycle) 54.7 87.7
** 47.9 750 12.5
Immobilized 
(18 cycles) 54.7 80.5





















Scheme 1. Oxidation of cyclohexanone to ε-caprolactone catalyzed by CHMO coupled to





























Figure 1. Activity  and stability profiles  of  CHMO and PTDH.  (A) CHMO activity was
measured at pH 5.0-10.0. (B) PTDH activity was measured at pH 7.0-9.0. (C) CHMO and
(D) PTDH stability towards pH was assayed by incubating the enzyme (1U/mL) in 50 mM
buffer: () acetate pH 5.0; () sodium phosphite pH 6.0; Tris-maleate: () pH 7.0, () pH
7.5; Tris-HCl: () pH 8.0, () pH 8.5, () pH 9.0 and () carbonate-bicarbonate pH 10.0.
















Figure  2. Oxidation  of  ()  cyclohexanone  to  ()  ε-caprolactone  catalyzed  by  soluble
CHMO/PTDH at  pH  7.0  (A)  and  pH  8.5  (B).  ()  Activity  of  the  soluble  bifunctional
biocatalyst. The reaction medium contained 25 mM cyclohexanone, 50 mM phosphite, 1mM



























Figure  3. Oxidation  of  ()  cyclohexanone  to  () ε-caprolactone  catalyzed  by
CHMO/PTDH immobilized on Co-IDA.  () Activity of the immobilized biocatalyst. The
reaction medium contained 25 mM cyclohexanone, 50 mM phosphite, 1mM NADP+ and 1 U

























Figure 4. () Oxidized and () reduced cofactor profiles during cyclohexanone oxidation to
ε-caprolactone  catalyzed  by  CHMO/PTDH.  A:  soluble  enzyme  (1  U  of  CHMO/mL of
reaction); B: enzyme immobilized on Co-IDA (1 U of CHMO/mL of reaction); C: enzyme























mM cyclohexanone, 50 mM phosphite and 1mM NADP+.  Oxidations were carried out at
25oC and pH 7.0.
Figure  5. Oxidation  of  ()  cyclohexanone  to  () ε-caprolactone  catalyzed  by
CHMO/PTDH  immobilized on  (A) MANA-agarose and (B) Co-IDA. () Activity of the
immobilized biocatalyst. The reaction medium contained 25 mM cyclohexanone,  50 mM
phosphite, 1mM NADP+  and 2 U of immobilized CHMO/mL of reaction.  Oxidations were






























Figure 6. Successive oxidation of cyclohexanone to  ε-caprolactone coupled with cofactor
regeneration catalyzed by CHMO/PTDH immobilized on (A) MANA-agarose and (B) Co-
IDA.  Conversion (gray bars) and product yield () after 2.5 or 2 hours (cycle time) are
depicted. The reaction medium contained 25 mM cyclohexanone, 50 mM phosphite, 1mM
NADP+ and 2 U of immobilized CHMO/mL of reaction. Oxidations were performed at 25 °C
and pH 7.0.
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